TWIST1 and gastric cancer: The activation of Twist1 by Rab31 facilitated through STAT3 stimulation and MUC-1 suppression reveals a novel Rab31/STAT3/MUC-1/Twist1/EMT axis implicated in the drug resistance and metastatic potential of gastric cancer [97].